UiPath (NYSE:PATH) Given Hold Rating at Needham & Company LLC

Needham & Company LLC reiterated their hold rating on shares of UiPath (NYSE:PATHFree Report) in a research note published on Friday, Benzinga reports.

A number of other research analysts have also issued reports on the stock. Scotiabank reduced their target price on shares of UiPath from $30.00 to $25.00 and set a sector perform rating on the stock in a report on Wednesday, May 29th. Evercore ISI reduced their target price on shares of UiPath from $27.00 to $13.00 and set an in-line rating on the stock in a report on Thursday, May 30th. Macquarie lowered shares of UiPath from an outperform rating to a neutral rating and reduced their target price for the company from $29.00 to $12.00 in a report on Monday, June 3rd. Wells Fargo & Company reduced their target price on shares of UiPath from $15.00 to $14.00 and set an equal weight rating on the stock in a report on Friday, June 21st. Finally, BMO Capital Markets increased their price objective on shares of UiPath from $14.00 to $15.00 and gave the stock a market perform rating in a report on Friday. Sixteen investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of Hold and an average target price of $17.71.

Get Our Latest Stock Analysis on UiPath

UiPath Trading Up 1.8 %

Shares of NYSE PATH opened at $12.19 on Friday. The stock has a market cap of $6.98 billion, a price-to-earnings ratio of -76.19 and a beta of 0.87. UiPath has a 52 week low of $10.37 and a 52 week high of $27.87. The company’s 50-day moving average price is $12.19 and its 200 day moving average price is $16.54.

UiPath (NYSE:PATHGet Free Report) last released its earnings results on Thursday, September 5th. The healthcare company reported $0.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.03 by $0.01. The company had revenue of $316.00 million for the quarter, compared to analyst estimates of $303.69 million. UiPath had a negative net margin of 8.13% and a negative return on equity of 3.89%. The firm’s quarterly revenue was up 10.0% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.09) EPS. As a group, research analysts expect that UiPath will post -0.22 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. raised its holdings in UiPath by 5.6% in the first quarter. Vanguard Group Inc. now owns 40,217,936 shares of the healthcare company’s stock valued at $911,741,000 after buying an additional 2,133,078 shares during the period. State Board of Administration of Florida Retirement System grew its position in UiPath by 0.5% in the first quarter. State Board of Administration of Florida Retirement System now owns 295,370 shares of the healthcare company’s stock valued at $6,696,000 after acquiring an additional 1,571 shares in the last quarter. Mitsubishi UFJ Trust & Banking Corp grew its position in UiPath by 4.2% in the first quarter. Mitsubishi UFJ Trust & Banking Corp now owns 231,694 shares of the healthcare company’s stock valued at $5,240,000 after acquiring an additional 9,393 shares in the last quarter. Acadian Asset Management LLC grew its position in UiPath by 245.1% in the first quarter. Acadian Asset Management LLC now owns 45,700 shares of the healthcare company’s stock valued at $1,032,000 after acquiring an additional 32,456 shares in the last quarter. Finally, Neuberger Berman Group LLC grew its position in UiPath by 38.4% in the fourth quarter. Neuberger Berman Group LLC now owns 20,133 shares of the healthcare company’s stock valued at $500,000 after acquiring an additional 5,586 shares in the last quarter. Hedge funds and other institutional investors own 62.50% of the company’s stock.

About UiPath

(Get Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

See Also

Analyst Recommendations for UiPath (NYSE:PATH)

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.